Want to see SE:GENI full AI Analyst Report?
Generic Sweden AB (GENI) Financial Statements
Generic Sweden AB Financial Overview
Generic Sweden AB's market cap is currently $456.03M. The company's EPS TTM is $2.58; its P/E ratio is 14.38; and it has a dividend yield of 4.72%. Generic Sweden AB is scheduled to report earnings on November 4, 2026, and the estimated EPS forecast is $0.67. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 183.71M | $ 176.45M | $ 142.59M | $ 127.73M | $ 114.23M |
| Gross Profit | $ 38.81M | $ 44.72M | $ 38.27M | $ 35.54M | $ 31.93M |
| Operating Income | $ 38.58M | $ 33.31M | $ 28.62M | $ 25.76M | $ 22.84M |
| EBITDA | $ 39.58M | $ 35.52M | $ 30.16M | $ 26.88M | $ 24.25M |
| Net Income | $ 31.04M | $ 27.25M | $ 23.31M | $ 20.45M | $ 18.13M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 58.24M | $ 40.62M | $ 37.20M | $ 32.60M | $ 31.07M |
| Total Assets | $ 105.14M | $ 88.97M | $ 77.42M | $ 68.04M | $ 59.42M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -58.24M | $ -40.62M | $ -25.20M | $ -32.60M | $ -31.07M |
| Total Liabilities | $ 38.55M | $ 33.75M | $ 31.01M | $ 29.57M | $ 29.11M |
| Stockholders' Equity | $ 66.59M | $ 55.22M | $ 46.41M | $ 38.47M | $ 30.31M |
| Cash Flow | |||||
| Free Cash Flow | $ 38.98M | $ 21.85M | $ 19.97M | $ 13.82M | $ 18.44M |
| Operating Cash Flow | $ 39.73M | $ 24.06M | $ 21.84M | $ 16.85M | $ 19.89M |
| Investing Cash Flow | $ -2.44M | $ 9.79M | $ -13.87M | $ -3.03M | $ -1.45M |
| Financing Cash Flow | $ -19.67M | $ -18.44M | $ -15.37M | $ -12.29M | $ -9.83M |
Currency in SEK